Description
Recombinant Human TRAIL/TNFSF10 Protein (aa 114-281, His Tag)(Active) | PKSH033130 | Gentaur US, UK & Europe Disrtribition
Synonyms: Tumor Necrosis Factor Ligand Superfamily Member 10; Apo-2 Ligand; Apo-2L; TNF-Related Apoptosis-Inducing Ligand; Protein TRAIL; CD253; TNFSF10; APO2L; TRAIL
Active Protein: Active protein
Activity: Recombinant Human TNF-related Apoptosis-inducing Ligand is produced by our E.coli expression system and the target gene encoding Val114-Gly281 is expressed with a 6His tag at the C-terminus.
Protein Construction: Recombinant Human TNF-related Apoptosis-inducing Ligand is produced by our E.coli expression system and the target gene encoding Val114-Gly281 is expressed with a 6His tag at the C-terminus.
Fusion Tag: C-6His
Species: Human
Expressed Host: E.coli
Shipping: This product is provided as lyophilized powder which is shipped with ice packs.
Purity: > 90 % as determined by reducing SDS-PAGE.
Endotoxin: < 1.0 EU per µg as determined by the LAL method.
Stability and Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Molecular Mass: 20.6 kDa
Formulation: Lyophilized from a 0.2 μm filtered solution of 20mM PB，150mM NaCl, pH7.4.
Reconstitution: Please refer to the printed manual for detailed information.
Background: Human TNFSF10 is a type II transmembrane protein with an intracellular N-terminus and a ‘TNF homology domain’ (THD) at the extracellular C terminus. TNFSF10 can interact with several distinct receptors. Two of these receptors that belongs to TNFR superfamily, DR4 (TRAIL-R1) and DR5 (TRAIL-R2/TRICK2), are plasma membrane proteins containing intracellular death domains essential for activating apoptosis. TNFSF10 is promising for cancer therapy because it is cytotoxic and activates apoptosis in the majority of malignant cells, but not in normal cells.
Research Area: N/A
